INSIDE PHARMA

INSIDE PHARMA

Share this post

INSIDE PHARMA
INSIDE PHARMA
Is Big Pharma malpractice opening the door to functional medicines?

Is Big Pharma malpractice opening the door to functional medicines?

Simple answer—YES!

Hedley Rees's avatar
Hedley Rees
Sep 05, 2022
∙ Paid
38

Share this post

INSIDE PHARMA
INSIDE PHARMA
Is Big Pharma malpractice opening the door to functional medicines?
30
Share

What is the evidence?

If Twitter is anything to go by, masses of people and parents are beginning to steer clear of even the regular vaccines, such as polio, given the SARS-CoV-2 injections experience. Similarly, there is growing suspicion that Big Pharma companies may not have a patient’s wellbeing top of mind when developing new medicinal products (that may be something of an understatement!).

Then there was all the stuff about vitamin D in the early days of C19, and the other elements, such as zinc, required to keep our bodies in a state to fight off disease.

You may well have your own sources that support your conviction that Mother Nature’s own remedies are far superior to man-made ones.

Whichever way we look at it, recent Pfizergate events may well have opened the door to the diagnosis and treatment of common functional illnesses.

Common functional illnesses

It was not until 8th May 2019 that I became aware of functional illnesses.

A good friend of mine, who attended my conference Med…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Hedley Rees
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share